L'Oréal Groupe's Cell BioPrint Portable Lab Takes the Guesswork Out of Skin Care (CES 2025 Debut)
Jan 6th, 2025
L’Oréal Cell BioPrint is scheduled to launch with an unspecified L'Oréal brand in Asia later in 2025.
L'Oreal Groupe
About 80% of consumers rely on guesswork to find their ideal skin care products, per data cited by L'Oréal Groupe. To solve this perennial problem, the company has brought its L’Oréal Cell BioPrint portable lab-on-a-chip device to CES 2025; the technology is claimed to assess key biomarkers to predict future signs of aging (ex: potential development of dark spots), assessing the skin's longevity (by providing an estimated biological age, which reveals how fast the skin is aging) and a determination of responsiveness to various active ingredients.
Log in to view the full article
About 80% of consumers rely on guesswork to find their ideal skin care products, per data cited by L'Oréal Groupe. To solve this perennial problem, the company has brought its L’Oréal Cell BioPrint portable lab-on-a-chip device to CES 2025; the technology is claimed to assess key biomarkers to predict future signs of aging (ex: potential development of dark spots), assessing the skin's longevity (by providing an estimated biological age, which reveals how fast the skin is aging) and a determination of responsiveness to various active ingredients.
The lab-on-a-chip system works like this:
A facial tape strip is placed on each individual's cheek; that strip is then placed into a buffer solution
The solution is loaded into the L’Oréal Cell BioPrint cartridge and inserted into the machine for analysis
The system's Skin Connect device takes several images of each individual's face and presents a short questionnaire about skin concerns and aging
Those answers, combined with the L’Oréal Cell BioPrint analyses, generates personalized insights
L’Oréal Cell BioPrint is scheduled to launch with an unspecified L'Oréal brand in Asia later in 2025.
The device uses advanced proteomics to generate personalized analyses on how individuals' protein composition affects their skin aging. Each analysis, which assesses biomarkers determined by L'Oreal, takes 5 minutes.
The technology, developed in partnership with Korean startup NanoEnTek (a producer of microfluidic lab-on-a-chip technology), "reveals how mechanisms in the human body can affect skin’s appearance," according to L'Oreal.
Taken together, the insights can reportedly help individuals slow the appearance of aging by determining the ideal actives for their skin (ex: retinol), thereby minimizing guesswork.
"At L'Oréal, we're always looking toward the future of beauty, blending cutting-edge discoveries with our long-standing beauty expertise," says Barbara Lavernos, deputy CEO in charge of research, innovation and technology at L’Oréal Groupe. "With skin being the largest organ, and a key part of people’s wellbeing, we are thrilled to unveil Cell BioPrint, an exclusive microfluidic lab-on-a-chip technology coupled with our century-long skin science leadership. With the Cell BioPrint device, we offer people the ability to discover deeper insights about their skin through specific biomarkers and to proactively address the beauty and longevity of their skin.”